CSIMarket Company Name, Ticker, Industry, else..
 
Pharmacyte Biotech Inc   (NASDAQ: PMCB)
 

PMCB's Market share relative to its competitors, as of Q4 2026

As of Q4 2026 (Revenue in Millions of $)

Date modified: 2026-05-17T23:02:03+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q4 2026		 MARKET SHARE
12 Months
Q4 2026		 MARKET SHARE
MRQ
Q4 2026		 MARKET SHARE
A Quarter Before
Q3 2026
Pharmacyte Biotech Inc 0.00 0.00% 0.00 % 0.00 %
Catalyst Pharmaceuticals Inc 596.96 45.24% 28.91% 51.25%
Vaxart Inc 255.61 19.37% 5.26% 13.17%
Geron Corporation 195.86 14.84% 10.03% 16.04%
Valneva Se 195.62 14.82% 14.82% 0.00%
Vir Biotechnology Inc 65.50 4.96% 46.24% -0.01%
8 more competitors available

Sign in to see all competitors for Pharmacyte Biotech Inc .

Sign In Create Free Account



PMCB's Market share relative to its competitors, as of Q4 2026 within the Biotechnology & Pharmaceuticals Industry
As of Q4 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2026		 MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
MRQ
Q4 2026		 MARKET SHARE

Q3 2026
Pharmacyte Biotech Inc 0.00% 0.00% 0.00 % 0.00 %
Vaxart Inc 49.34% 47.86% 8.62% 40.28%
Valneva Se 37.76% 38.31% 37.76% 38.31%
Vir Biotechnology Inc 12.64% 13.83% 75.73% -0.03%
Scinai Immunotherapeutics Ltd 0.25% 0.00% 0.25% 0.00%
Aptose Biosciences Inc 0.00% 0.00% 0.00% 0.00%
4 more companies available

Sign in to see all industry competitors for Pharmacyte Biotech Inc .

Sign In Create Free Account



PMCB's Market share relative to its competitors, as of Q4 2026 within the Healthcare Sector
As of Q4 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2026		 MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
MRQ
Q4 2026		 MARKET SHARE

Q3 2026
Pharmacyte Biotech Inc 0.00% 0.00% 0.00 % 0.00 %
Catalyst Pharmaceuticals Inc 45.24% 46.16% 28.91% 51.25%
Vaxart Inc 19.37% 18.59% 5.26% 13.17%
Geron Corporation 14.84% 14.39% 10.03% 16.04%
Valneva Se 14.82% 14.88% 14.82% 14.88%
Vir Biotechnology Inc 4.96% 5.37% 46.24% -0.01%
8 more companies available

Sign in to see all sector competitors for Pharmacyte Biotech Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Pharmacyte Biotech Inc's market divisions, geographic dispersion, segments, products, and services, visit Pharmacyte Biotech Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.